DCM
AEON.WS

Dupont Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Dupont Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-49,999
Closed -$72.5K – 159
2024
Q1 		$72.5K Hold
49,999
– – 0.01% 64
2023
Q4 		$4.37K Hold
49,999
– – ﹤0.01% 77
2023
Q3 		$7.5K Hold
49,999
– – ﹤0.01% 109
2023
Q2 		$4.5K Hold
49,999
– – ﹤0.01% 506
2023
Q1 		$3.28K Hold
49,999
– – ﹤0.01% 624
2022
Q4 		$2.28K Hold
49,999
– – ﹤0.01% 1229
2022
Q3 		$4K Hold
49,999
– – ﹤0.01% 1344
2022
Q2 		$8K Hold
49,999
– – ﹤0.01% 1402
2022
Q1 		$16K Hold
49,999
– – ﹤0.01% 1458
2021
Q4 		$25K Hold
49,999
– – ﹤0.01% 1501
2021
Q3 		$27K Hold
49,999
– – ﹤0.01% 1502
2021
Q2 		$50K Buy
+49,999
New +$37.9K ﹤0.01% 1469

Dupont Capital Management's AEON.WS Position: Q2 2024 in Review

Dupont Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 49,999 shares — an estimated $72.5K sold.

Dupont Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $72.5K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

  • Dupont Capital Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
  • Dupont Capital Management sold 49,999 AEON Biopharma Inc shares in Q2 2024, an estimated $72.5K.
  • Dupont Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
  • Dupont Capital Management's AEON Biopharma Inc position peaked at $72.5K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Dupont Capital Management's 13F filing for Q2 2024, filed 18 Jul 2024.